JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Abstract Details

Activity Number: 404
Type: Contributed
Date/Time: Tuesday, July 31, 2012 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract - #305804
Title: Two-stage futility analysis in phase III adaptive trials with time-to-event endpoint
Author(s): Xiaoyun (Nicole) Li*+ and Cong Chen
Companies: Merck & Co. and Merck
Address: UG 1C-46, 375 Sumneytown Pike,, Upper Gwynedd, , USA
Keywords: Benefit-cost ratio ; survival analysis ; adaptive design ; oncology phase III trials

Interim futility analysis is a critical component in oncology phase III studies due to high failure rate in spite of strong efficacy signals observed in phase II trials. For phase III trials with a time-to-event endpoint, a typical interim futility analysis is performed. We propose a two-stage futility analysis in phase III adaptive trials with a time-to-event endpoint to decide whether to continue enrollment or stop the trial completely in the early portion of the study without any requirement on minimum follow-up time. This approach is appropriate if the proportional hazard assumption is valid. However, it is rarely true in practice that proportional hazard assumption holds. We propose a two-stage interim futility design that allows a third option: pause enrollment and wait for mature follow up. To prevent operational challenge and save time, a stage-one futility analysis is performed without requirement on minimal follow-up. In case the futility bar has not crossed, we pause the study and wait for data to mature to make a final decision at stage-two. This approach mitigates the risk of stopping early for futility when it takes time for the study drug to differentiate from the control. We perform a simulation study to illustrate and compare this proposed design with conventional futility designs.

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2012 program

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.